Literature
Literature
2.50 h M2 0,00 0
2.50 h Pronuclei 25,00 7
2.50 h NEBD 21,43 6
2.50 h Metaphase 14,29 4
2.50 h Anaphase 7,14 2
2.50 h Telophase 17,86 5
2.50 h ≥ 2-cell 14,29 4
TOTAL 28
2.67 h M2 7,14 1
2.67 h Pronuclei 28,57 4
2.67 h NEBD 14,29 2
2.67 h Metaphase 7,14 1
2.67 h Anaphase 14,29 2
2.67 h Telophase 0,00 0
2.67 h ≥ 2-cell 28,57 4
TOTAL 14
2h* M2 23,68 9
2h* Pronuclei 31,58 12
2h* NEBD 15,79 6
2h* Metaphase 10,53 4
2h* Anaphase 0,00 0
2h* Telophase 2,63 1
2h* ≥ 2-cell 15,79 6
TOTAL 38
2 h ** M2 9,30 4
2 h ** Pronuclei 44,19 19
2 h ** NEBD 11,63 5
2 h ** Metaphase 6,98 3
2 h ** Anaphase 0,00 0
2 h ** Telophase 16,28 7
2 h ** ≥ 2-cell 11,63 5
TOTAL 43
Article Title Journal Year DOI Relevant points
-Heparin could imrpove oocyte maturation as is a common component of ooplasm,
follicular fluid. Heparin reduces oocyte development: the appereance of 1 polar body
Heparin effect on in vitro nuclear maturation of
and GV breakdown occurs earlier. It might also support IVF, since parental pronuclei
bovine oocytes develop better with this treatment. No effects on embryos are seen. Heparin is also
Zygote 2008 10.1017/S0967199407004418 used for capacitation of sperm.